The Association of the British Pharmaceutical Industry (ABPI) Code of Practice requires all companies to document and publicly disclose certain transfers of value (ToVs) made directly or indirectly to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) located in Europe, as well as to research & development (R&D) projects and patient organisations.
Working with HCPs/ORDMs and HCOs
Merz is committed to compliance and working within the ABPI Code of Practice and applicable laws. For payments made to HCPs/ORDMs and HCOs, including R&D projects in the last three years (2016, 2017 and 2018), please refer to the ABPI Disclosure Database:
Working with patient groups
Merz have also made the following contributions to working with patient groups in 2016, 2017 and 2018:
Contributions to Patient Organisations in 2016
Contributions to Patient Organisations in 2017
Contributions to Patient Organisations in 2018